BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
BioCircuit Technologies has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
BioCircuit Technologies's investors include National Institutes of Health, Alsora Capital, Michael W. Masters, GRA Venture Fund.
BioCircuit Technologies is headquartered in Atlanta, United States.
BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.
BioCircuit Technologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCircuit Technologies — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/biocircuit-technologies. Accessed September 30, 2026.
VCBacked. (2024). BioCircuit Technologies — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biocircuit-technologies
{{cite web |title=BioCircuit Technologies — Funding & Investors |url=https://www.vcbacked.co/company/biocircuit-technologies |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated